Johnson & Johnson financial data

Symbol
JNJ on NYSE
Industry
Pharmaceutical Preparations
Location
One Johnson & Johnson Plz, New Brunswick, NJ
State of incorporation
NJ
Fiscal year end
December 29
Former names
JOHNSON & JOHNSON ET AL (to 1/23/1996)
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 109 % -3.32%
Quick Ratio 23.7 % +1.32%
Debt-to-equity 149 %
Return On Equity 19.9 % -59.4%
Return On Assets 7.91 % -59.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.41B shares -0.05%
Entity Public Float 352B USD -18.1%
Common Stock, Value, Issued 3.12B USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.41B shares -4.98%
Weighted Average Number of Shares Outstanding, Diluted 2.43B shares -5.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 88.8B USD +4.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 16.7B USD +10.8%
Income Tax Expense (Benefit) 2.62B USD +51%
Net Income (Loss) Attributable to Parent 14.1B USD -60%
Earnings Per Share, Basic 5.84 USD/shares -58.1%
Earnings Per Share, Diluted 5.79 USD/shares -58.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.1B USD +10.3%
Marketable Securities, Current 417M USD -61%
Cash, Cash Equivalents, and Short-term Investments 20.3B USD -13.7%
Accounts Receivable, after Allowance for Credit Loss, Current 14.8B USD -0.21%
Inventory, Net 12.4B USD +11.3%
Assets, Current 55.9B USD +4.48%
Deferred Income Tax Assets, Net 10.5B USD +12.7%
Property, Plant and Equipment, Net 20.5B USD +3.12%
Operating Lease, Right-of-Use Asset 1.1B USD +10%
Intangible Assets, Net (Excluding Goodwill) 37.6B USD +10.1%
Goodwill 44.2B USD +20.9%
Other Assets, Noncurrent 11.4B USD -19.4%
Assets 180B USD +7.49%
Accounts Payable, Current 10.3B USD +7.05%
Employee-related Liabilities, Current 4.13B USD +3.33%
Accrued Liabilities, Current 8.55B USD -16.3%
Liabilities, Current 50.3B USD +8.73%
Accrued Income Taxes, Noncurrent 390M USD -86.5%
Deferred Income Tax Liabilities, Net 2.45B USD -23.3%
Other Liabilities, Noncurrent 17.5B USD +31%
Liabilities 109B USD +9.95%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11.7B USD +6.27%
Retained Earnings (Accumulated Deficit) 156B USD +1.27%
Stockholders' Equity Attributable to Parent 70.2B USD -1.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 71.5B USD +3.95%
Liabilities and Equity 180B USD +7.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.66B USD +12.3%
Net Cash Provided by (Used in) Financing Activities 546M USD -91.1%
Net Cash Provided by (Used in) Investing Activities -464M USD -114%
Common Stock, Shares Authorized 4.32B shares 0%
Common Stock, Shares, Issued 3.12B shares 0%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.61B USD -71.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.1B USD +10.3%
Deferred Tax Assets, Valuation Allowance 1.64B USD +42.6%
Deferred Tax Assets, Gross 16.8B USD +21.8%
Operating Lease, Liability 1.2B USD +9.09%
Payments to Acquire Property, Plant, and Equipment 807M USD -6.49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.43B USD -94.5%
Property, Plant and Equipment, Gross 48.8B USD +2.08%
Deferred Income Tax Expense (Benefit) -1.56B USD -1.23%
Deferred Tax Assets, Operating Loss Carryforwards 2.3B USD +7.13%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 2.02B USD -18.7%
Amortization of Intangible Assets 4.5B USD 0%
Depreciation, Depletion and Amortization 1.82B USD -3.46%
Deferred Tax Assets, Net of Valuation Allowance 15.2B USD +19.9%
Interest Expense 715M USD +49.6%